Standalone total income stood at Rs 1,658.2 million for the quarter under review. It was at Rs 1,598.2 million for the same period a year ago.
The company also said its board has approved the buyback proposal for the purchase of its 20.6 million equity shares for an aggregate amount not exceeding Rs 8,858 million from the shareholders of the company.
The board noted the intention of the promoters and promoter group of the company to participate in the proposed buyback.
Shares of Unichem Laboratories on Monday closed at Rs 369.25 per scrip on BSE, up 5.03 per cent from the previous close.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)